TLR4 and neoplasm: DAMPs and PAMPs from infection-related inflammatory, tumor-associated inflammatory, or antitumor therapy-induced inflammatory could upregulate the TLR4 expression and activate TLR4 signaling in tumor cells and contribute tumor pathogenesis and progression in a direct or indirect way (33–35).